Effect of Cetirizine on Early- and Late-Phase Airway Responses in a Brown Norway Rat Model of Allergic Asthma
Public Domain
-
2007/01/01
Details
-
Personal Author:
-
Description:Rationale: The effect of Cetirizine, a selective H1-receptor antagonist, was studied in the Brown Norway rat (BNR) model of trimellitic anhydride (TMA) early and late phase allergic asthma. Methods: Rats were sensitized by 4 hr, weekly applications of 40 mg dry TMA powder on the rats' dorsum for 4 weeks. Two weeks after the final exposure, BNR were challenged with a 10 min, 40 mg/m3 TMA aerosol inhalation exposure and enhanced pause (Penh, an index of airway resistance) was recorded continuously overnight. Cetirizine (15 or 30 mg/kg, i.p.) was given 30 min before or 1 hr after TMA challenge. Results: Both doses of Cetirizine when administered 1 hr after TMA challenge attenuated the late-phase airway response (LAR). Thirty mg/kg Cetirizine administered prior to airway challenge did not inhibit the early-phase airway response (EAR), but again the late-phase airway response was inhibited. Conclusions: The data suggest that the H-1 histamine receptor does not play a major role in the EAR, but is involved in LAR physiological response in the BNR TMA allergic asthma model. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0091-6749
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:119
-
Issue:1
-
NIOSHTIC Number:nn:20031551
-
Citation:J Allergy Clin Immunol 2007 Jan; 119(1)(Suppl 1):S301
-
Federal Fiscal Year:2007
-
NORA Priority Area:
-
Peer Reviewed:False
-
Source Full Name:Journal of Allergy and Clinical Immunology
-
Supplement:Suppl 1
-
Collection(s):
-
Main Document Checksum:urn:sha-512:b6291f34cd550a9221b19878f48b35df3e3a9a348e897e06f51ce3ccd1d1f86a14d4bc39f97de375457d21f840f90b9a3fae7c7a5392aabfdf876eb0b51c0681
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like